Pasithea Therapeutics annual gross margin
2021
2022
Pasithea Therapeutics Gross Margin Growth & History (KTTA)
Pasithea Therapeutics's gross margin was 76.74% for fiscal 2022.
View full Pasithea Therapeutics company overviewPasithea Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | 76.74% | +91.43 pp |
| 2021 | 2021-12-31 | −14.69% | — |
Pasithea Therapeutics quarterly gross margin
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | 100.54% | — |
| Q3 2022 | 2022-09-30 | 60.45% | — |
| Q2 2022 | 2022-06-30 | −11.19% | — |
| Q1 2022 | 2022-03-31 | 5.28% | — |
Pasithea Therapeutics gross margin trends
Between the periods ended 2021-12-31 and 2022-12-31, Pasithea Therapeutics's gross margin increased from −14.69% to 76.74%, a change of +91.43 percentage points. The latest reported quarter, Q4 2022, shows 100.54%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pasithea Therapeutics source filings ↗